Deal overview
| Target | BIO-TECHNE CORPORATION |
|---|---|
| Bidder | MERCK KGAA |
| Price | £90.00 Full version or £25.00 Light version |
| Publication Date | Jun 25, 2026 |
| Abstract | On 25 June 2026, the quoted German science and technology company Merck KGaA ("Merck") announced that it had entered into a definitive agreement to acquire the US-quoted provider of life science tools, analytical technologies and consumables Bio-Techne Corporation ("Bio-Techne"). Merck would pay US$73 per share in cash, representing a total equity value of approximately ... |
| Number of pages (Full version) | 9 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2026 M&A Monitor Limited
